Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
Download real time
2205.10
-14.10
(
-0.64
%)
New 52W High in past week
5,398
NSE Volume
High vol.+gain this week
NSE
15 Jul, 2025 9:07 AM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Analyst Buy
Motilal Oswal retains 'Buy' call on Glenmark Pharma, expects a revenue CAGR of 10.6% over FY26-27
See details
Overview
Buy Sell Zone
F&O
Financials
Forecaster
Competitors/Peers
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Documents
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(5)
About
Glenmark Pharmaceuticals Ltd. - Earnings Conference Call